New Hope Clinical Research   Report issue

For profit Phase 1 Phase 3
Founded: Charlotte NC United States (2009)

Organization Overview

First Clinical Trial
2013
NCT01887678
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

New Hope Clinical Research, Inc.

Active Ingredients

Drugs in Phase 3 Trials (2)

traumeel (1 trial)

zeel (1 trial)

Drugs in Phase 1 Trials (1)

asenapine (saphris) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bipolar Disorder (Phase 1)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Schizophrenia (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3